from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1312/-

LFCtreatmentdescriptionclass of inhibitor

-2.144

Amikacinug/mL Amikacintranslation

-2.413

Cap5-10ug/mL Capreomycintranslation

-2.416

Rox10-50 ug/mL Roxithromycintranslation

-0.881

SM2-5 ug/mL Streptomycintranslation

-2.481

Tet5-10 ug/mL Tetracyclinetranslation

0.056

Rif0.2-5ug/mL Rifampicintranscription

0.135

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.026

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.183

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.169

CPZ10-50 ug/mL Chlorpromazinerespiration

0.139

Clofazimine10-13 ug/mL Clofaziminerespiration

0.571

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.157

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.634

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.326

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.446

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.310

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.407

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.574

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.623

KCN5-20 ug/mL Potassium cyaniderespiration

0.853

NaN30.2-2 mM Sodium aziderespiration

-0.159

Nigericin50 uM Nigericinrespiration

-0.704

TRC10-150 ug/mL Triclosanrespiration

-0.711

TRZ10-25 ug/mL Thioridazinerespiration

-2.019

Valinomycin0.5-10 uM Valinomycinrespiration

0.465

ZnSO42 mM ZnSO4respiration

-0.917

menadione6-10 ug/mL Menadionerespiration

0.545

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.393

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.785

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.426

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.760

NRP_1Non-replicating persistence stage 1dosRassociated

0.886

Amp0.2mg/mL AmpicillincellWall

0.318

Cephalexin20-100 ug/mL CephalexincellWall

-0.674

Cerulenin0.32-5 ug/mL CerulenincellWall

0.663

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.149

EMB10-20 ug/mL EthambutolcellWall

0.286

Eta12-40 ug/mL EthionamidecellWall

0.500

INH0.2-0.4 ug/mL IsoniazidcellWall

0.723

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.858

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.863

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.342

BZA0.12 mg/mL BenzamidearomaticAmides

0.008

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.358

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.316

H2O24 mM hydrogen peroxideDNAdamaging

-0.599

Levo10 ug/mL LevofloxacinDNAdamaging

0.638

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.543

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.387

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.368

UVUV-irradiationDNAdamaging

0.403

ARP41-4 ug/mL Antitubercular compound ARP4?

0.727

Antimycin12.5-50 ug/mL Antimycin A?

0.482

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.161

PA_110-50 ug/mL Antitubercular compound PA-1?

1.292

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.516

PA8240.2-2 ug/mL PA-824?

-1.208

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.382

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.396

Verapamil50 uM Verapamil?

0.355

mercaptoethanol2 mM 2-Mercaptoethanol?

0.290

methoxatin10-20 ug/mL Methoxatin?